FHIT Gene Therapy Apoptosis Induction via Viral Vector Delivery

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

There is a need for methods to alter the expression of the FHIT gene in subjects, particularly in cancer-related disorders, and compositions that can effectively manage FHIT expression to prevent tumorigenesis and induce apoptosis in malignant cells.

Innovation Solution

The development of methods to identify proteins interacting with Fhit, such as Hsp60, Hsp10, and Fdxr, which are involved in downstream signal pathways leading to apoptosis, and the use of viral-mediated FHIT gene therapy to restore Fhit expression in cancer cells, thereby inducing apoptosis and suppressing tumorigenesis.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If viral-mediated Fhit restoration is used to suppress tumorigenesis and trigger apoptosis, then cancer cell death is enhanced, but the complexity of the gene therapy process increases

Engineering Contradiction:
Improvecancer cell apoptosis inductionVSAvoidgene therapy process complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent uses viral vectors as intermediaries to deliver Fhit gene into cancer cells. The virus acts as a mediator that facilitates gene transfer without requiring direct manipulation of cellular machinery, thereby achieving reliable apoptosis induction while managing the complexity of the delivery process through a standardized viral vector system

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If Fhit expression is restored in cancer cells, then tumorigenesis is suppressed, but the stability of Fhit expression in vitro is insufficient without stress exposure

Engineering Contradiction:
Improvetumorigenesis suppressionVSAvoidFhit expression stability
Core Design Contradiction:
ReliabilityVSStability of the object's composition

Solution Approach 1:

The patent applies stress conditions (such as oxidative stress or DNA damaging agents) in advance to cancer cells expressing Fhit. This preliminary stress exposure prevents the instability of Fhit expression by activating pathways that maintain Fhit function and enhance its anti-tumorigenic effects, ensuring reliable tumorigenesis suppression

Inventive Principle:
Principle #9Preliminary anti-action

3Loss of information

If proteins interacting with Fhit are identified to understand apoptotic pathways, then mechanistic understanding is improved, but the complexity of protein interaction analysis increases

Engineering Contradiction:
Improveapoptotic pathway informationVSAvoidprotein interaction analysis complexity
Core Design Contradiction:
Loss of informationVSDevice complexity

Solution Approach 1:

The patent employs co-immunoprecipitation and mass spectrometry approaches where Fhit protein serves as a bait to pull down interacting proteins. The identified interactors provide feedback information about apoptotic pathways, allowing systematic mapping of protein-protein interactions while using standardized biochemical methods to manage analytical complexity

Inventive Principle:
Principle #23Feedback

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The approach effectively triggers apoptosis in cancer cells, enhances sensitivity to chemotherapeutic agents, and suppresses tumorigenicity by restoring Fhit expression and interacting with mitochondrial proteins to generate reactive oxygen species, leading to increased cell death in cancer cells.

Implementation Method 1

Fhit interaction with mitochondrial proteins to generate reactive oxygen species, leading to increased cell death in cancer cells

Methodology Applied
Scientific EffectOxidative stress: Oxidation

Data Source

PatentUS8911998B2Methods for identifying fragile histidine triad (FHIT) interaction and uses thereof
Publication Date: 2014.12.16 THE OHIO STATES UNIV
  • US8911998B2 patent drawing
  • US8911998B2 patent drawing
  • US8911998B2 patent drawing

AI summary

Provided herein are methods and compositions for the diagnosis, prognosis and treatment of a cancer associated disorder using the Fhit gene.